Mariana Mazzucato · 2013

The Entrepreneurial State

Debunking Public vs. Private Sector Myths

Rough AI truth score

67/100

Mazzucato is right that public agencies fund foundational science, mission research, procurement, and risky technological capabilities, and evidence shows public research can stimulate private patents. The leap from that record to the state as a generally superior entrepreneurial selector is not established. Innovation is an ecosystem of public science, competitive firms, finance, institutions, users, and execution.

Based on three central claims · high confidence

The three claims

01Mostly supported

Public agencies have financed foundational technologies and basic or mission-oriented research that private investors underprovide.

Official R&D accounts and the histories of NIH, NSF, defense, space, and energy programs show sustained public financing across long horizons and uncertain fields. Private firms also fund most U.S. R&D overall and are central to development, manufacturing, scaling, and market discovery, so origin stories should assign complementary credit.

NSF: Long-Term Trends in Federally Funded R&D NSF: Translation to Impact

02Mostly supported

Public research funding can causally stimulate complementary private innovation rather than merely displacing it.

NIH funding-rule designs provide causal evidence that marginal public research funding increases related private patenting, supporting knowledge spillovers and complementarity. Effects vary by field, instrument, time horizon, and outcome; targeted funding does not guarantee late-stage products or commercial success.

Public R&D Investments and Private-Sector Patenting Public Financing of Innovation: New Questions

03Mixed

The state is generally better positioned than decentralized firms and investors to choose and develop the technological directions that drive long-run growth.

Mission-oriented agencies can coordinate infrastructure, tolerate uncertainty, set direction, and finance spillovers that markets underprovide. Public organizations also face information, incentive, capture, portfolio, and evaluation failures, while competitive entry and independent entrepreneurship discover uses and cost structures no central selector can know.

Bureaucrats or Markets in Innovation Policy? IMF: R&D, Innovation, and Economic Growth

Other claims worth checking

Public risk-taking should be paired with mechanisms that share upside and govern downside.
Innovation policy should evaluate portfolios rather than only visible winners.

What this number means. It is an AI-generated first-pass judgment of three central factual or causal claims—not a rating, exhaustive fact-check, or human peer review. Claim credits are 100% for supported, 75% for mostly supported, 50% for mixed, and 25% for weak, then averaged and rounded. Lower confidence means the score should move more as better evidence arrives.

Method three-central-claims/0.1.0 · checked 2026-09-01 · 3/3 selected claims assessed · method and source audit